Skip to main content
Log in

Effects of phenylpropanolamine on withdrawal symptoms

Psychopharmacology Aims and scope Submit manuscript

Abstract

A prior report (Klesges et al. 1990) suggested that phenylpropanolamine (PPA) was successful in reducing the smoking withdrawal symptom of weight gain in a sample of women. The current investigation evaluates whether the effects of phenylpropanolamine (PPA; up to 10/day PPA gums) on withdrawal symptoms associated with smoking cessation are specific to weight and weight-related symptoms or whether PPA alleviates withdrawal in general. One hundred and seven adult smokers (56 men, 51 women) were randomly assigned, in this double-blind trial, to chew either 8.33 mg phenylpropanolamine gum or a placebo gum. Subjects were then aided to quit smoking for 4 weeks. PPA did not enhance cessation rates. Results from the 47 subjects who successfully quit smoking indicated that postcessation weight gain and ratings of hunger were significantly reduced in both men and women for those assigned to the PPA group relative to the placebo group. Overall, no effects of PPA relative to placebo were observed for other smoking-related withdrawal symptoms. Thus, although PPA appears to reduce weight gain and alleviate weight-related symptoms, no effects on other withdrawal symptoms were observed. Future research directions are suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • APA (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised). American Psychological Association, Washington DC

    Google Scholar 

  • Camp DE, Klesges RC, Relyea G (1993) The relationship between body weight concerns and adolescent smoking. Health Psychol 12:24–32

    Google Scholar 

  • Charlton A (1984) Smoking and weight control in teenagers. Public Health London 98:277–281

    Google Scholar 

  • Daughton DM, Heatley SA, Pendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, Rennard SI (1991) Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double blind study. Arch Int Med 151:749–752

    Google Scholar 

  • Emont SL, Cummings KM (1987) Weight gain following smoking cessation: a possible role for nicotine replacement in weight management. Addict Behav 12:151–155

    Google Scholar 

  • Glasgow RE, Klesges RC, Godding PR, Gegelman R (1983) Controlled smoking, with or without carbon monoxide feedback, as an alternative for chronic smokers. Behav Ther 14:386–397

    Google Scholar 

  • Greenway FL (1992) Clinical studies with phenylpropanolamine: a metaanalysis. Am J Clin Nutr 55:203S-205S

    Google Scholar 

  • Gross J, Stitzer ML, Maldonado J (1989) Nicotine replacement: effects on post-cessation weight gain. J Consult Clin Psychol 57:87–92

    Google Scholar 

  • Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294

    Google Scholar 

  • Hughes JE, Frederiksen LW, Frazier M (1978) A carbon monoxide analyzer for measurement of smoking behavior. Behav Ther 9:293–296

    Google Scholar 

  • Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW (1991) Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry 48:52–59

    Google Scholar 

  • Hughes JR, Gulliver SB, Solomon LJ, Flynn BS (1992) Smoking cessation and tobacco withdrawal symptoms in self-quitters. Poster presented at: Society For Behavioral Medicine Annual Meeting, New York, New York

  • Hunt WA, Bespalec DA (1974) An evaluation of current methods of modifying smoking behavior. J Clin Psychol 30:431–438

    Google Scholar 

  • Klesges RC, Klesges LM (1988) Cigarette smoking as a dieting strategy in a university population. Int J Eating Disord 7:413–419

    Google Scholar 

  • Klesges RC, Klesges LM, Meyers AW, Klem ML, Isbell T (1990) The effects of phenylpropanolamine on dietary intake, physical activity, and body weight following smoking cessation. Clin Pharmacol Ther 47:747–754

    Google Scholar 

  • Lasagna L (1988) Phenylpropanolamine: A review. Wiley, New York

    Google Scholar 

  • Morgan JP (1986) Phenylpropanolamine: a critical analysis of reported adverse reactions and overdosage. Jack K. Burgess, Fort Lee, New Jersey

    Google Scholar 

  • Morgan JP, Kagan DV, Brody JS (eds) (1985) Phenylpropanolamine: risks, benefits, and controversies. Praeger Publishers Division, Westport, Connecticut

    Google Scholar 

  • Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H (1992) Smoking cessation in women concerned about weight. Am J Public Health 82:1238–1243

    Google Scholar 

  • Sachs DPL, Leischow SJ (1991) Pharmacologic approaches to smoking cessation. Clin Chest Med 12:769–791

    Google Scholar 

  • Schwartz JL (1987) Review and evaluation of smoking cessation methods: the United States and Canada, 1978–1985. National Cancer Institute, US Dept. of Health and Human Services. (NIH Publ. No. 87-940), Division of Cancer Prevention, Bethesda, MD

    Google Scholar 

  • Spring B, Wurtman J, Gleason R, Wurtman, Kessler K (1991) Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention usingd-fenfluramine. Health Psychol 10:216–223

    Google Scholar 

  • Spring B, Pingitore R, Kessler K (1992) Strategies to minimize weight gain after smoking cessation: psychological and pharmacological intervention with specific reference to dexfenfluramine. Int J Obes 16:519–523

    Google Scholar 

  • Tonnesen P, Norregaard J, Simonsen K, Sawe U (1991) A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 325:311–315

    Google Scholar 

  • Transdermal Nicotine Study Group (1991) Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 266:3133–3138

    Google Scholar 

  • United States Department of Health and Human Services (1990) The Health Benefits of Smoking Cessation. A Report of the Surgeon General (DHHS Publ. No. (CDC) 90-8416). US Government Printing Office

  • United States Department of Health and Human Services (1985) The health consequences of smoking: cancer and chronic lung disease in the workplace. A report of the Surgeon General (DHHS Publ. No. PHS85-50207). US Government Printing Office

  • United States Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction. A Report of the Surgeon General (DHHS Publ. No. (CDC) 88-8406). US Government Printing Office

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klesges, R.C., Klesges, L.M., DeBon, M. et al. Effects of phenylpropanolamine on withdrawal symptoms. Psychopharmacology 119, 85–91 (1995). https://doi.org/10.1007/BF02246058

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246058

Key words

Navigation